FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug

1 month ago  |  Views: 9

Share Statistics! ↓

Eli Lilly expected a decision on donanemab in this year’s first quarter, which ends this month. Read More
Read Entire Article

   
Advertise | Terms | Contact | Sitemap

       

© 2024 BuzzCo News, all rights reserved